BBOTVSIMMP• 7 Days (Normalized)
BBOT vs IMMP (BridgeBio Oncology Therapeutics Inc. vs Immutep Limited)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-1.52%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
IMMP Performance $4.35
+1573.08%
Immutep Limited
Normalized Baseline0.00%
Alpha Spread Margin IMMP LEADS
-1574.6 pts
IMMP outperforming by 1574.60 percentage points
BBOTIMMP
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT IMMP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | BBOT Price | BBOT Gain (%) | IMMP Price | IMMP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -1.52% | $4.35 | +1573.08% | -1574.60% |
| Oct 01, 2026 | $- | $4.54 | +1646.15% | - | |
| Sep 30, 2026 | $4.10 | +3.80% | $4.65 | +1688.46% | -1684.66% |
| Sep 29, 2026 | $3.92 | -0.76% | $4.71 | +1711.54% | -1712.30% |
| Sep 28, 2026 | $3.81 | -3.54% | $- | - | |
| Sep 25, 2026 | $3.95 | +0.00% | $0.26 | +0.00% | +0.00% |